Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8526336 | Biomedicine & Pharmacotherapy | 2018 | 9 Pages |
Abstract
In addition to previously studied DPPIV inhibitor, PTY-2 also acts as incretin receptors agonist and protects against STZ-induced diabetes by down regulating β cells apoptosis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Shivani Srivastava, Priya Shree, Harsh Pandey, Yamini Bhusan Tripathi,